Glaukos Corporation — Quarterly Financial Statistics (NYSE:GKOS) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 9.59 M-525 K18.52 M-6.98 M10.09 M-6.84 M 14.79 M Cash from investing activities 30.56 M11.79 M36.95 M20.78 M3.99 M15.89 M 77.61 M Cash from financing activities 9.67 M60.11 M1.95 M2.25 M5.26 M2.43 M 11.89 M Free cash flow 8.14 M-2.26 M16.58 M-8.16 M8.46 M-9.76 M 7.12 M

뉴스

스티펠, Glaukos에 대한 ’매수’ 등급 재확인

Stifel reiterates Glaukos stock rating on product momentum

Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook

글라우코스, iDose 및 Epioxa 성장세에 Needham 목표가 상향

Needham raises Glaukos stock price target on iDose, Epioxa growth

These Analysts Boost Their Forecasts On Glaukos Following Q4 Results - Glaukos (NYSE:GKOS)

Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript

Glaukos (GKOS) Reports Q4 Earnings: What Key Metrics Have to Say

Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates

글라우코스, iDose·Epioxa 출시 시점 맞아 실적 발표 예정

Glaukos earnings on deck as iDose, Epioxa launches converge

Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth